Welcoming a new Partner to our team, Simon Pannett

2 mins read
Scroll

Putnam is pleased to welcome Simon Pannett as Partner within our HTA and Market Access team.

Simon brings a wealth of experience and leadership to Putnam having been advising clients across the pharmaceutical and life sciences industries throughout his career. He has a proven track record of guiding assets through every stage of the market access journey—from early strategy development to HTA delivery, reimbursement, and commercial implementation. His deep expertise spans a broad range of therapeutic areas, including hematology, oncology, ophthalmology, neurology, and rare diseases.

Throughout his career, Simon has led high-impact projects resulting in successful HTA submissions, innovative pricing strategies, and meaningful commercial outcomes. His work has consistently enabled clients to achieve optimal patient access and long-term value for their assets.

Prior to joining Putnam, Simon’s career has seen him successfully lead a boutique multi-practice European consultancy and has worked in numerous roles at small and large pharmaceutical companies, the medical device industry, and digital health.

Reflecting on his new role, Simon shared:
“Throughout my career, I’ve been driven by a commitment to making a tangible difference in patients’ lives by improving access to vital treatments and services. I proactively challenge the status quo to develop innovative solutions for unmet needs. Joining Putnam and the Inizio group presents an exciting opportunity to collaborate with a broader network of experts and leverage a wider range of services. I am eager to contribute to bringing life-changing innovations to clinicians and patients, while also continuing my professional growth through learning from my new colleagues across the group.”

We’re thrilled to welcome Simon to Putnam and look forward to the impact he will make for our clients and their patients.


About Putnam

Putnam is a leading scientific and strategic consulting partner that helps the global life science community make confident decisions, build value, and bring life-changing innovations to clinicians and patients. For over 30 years, our rigorous, bespoke approach and globally diverse team have maximized the human impact and commercial success of client innovations.